The PROMISE Survey
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Apr 17, 2025
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
The PROMISE Survey is a study designed to gather information about the experiences of patients with prolactinomas, which are tumors in the pituitary gland that can affect hormone levels. This survey aims to understand how patients and their doctors feel about current treatments, what side effects they experience, and the overall outcomes of their care. By collecting this information, the researchers hope to improve future treatments and personalized care for those with prolactinomas.
To participate in this survey, you need to be a patient diagnosed with a prolactinoma or a physician who treats these patients, such as an endocrinologist or neurosurgeon. The study is set to begin but is not yet recruiting participants. If you're eligible, you can expect to share your experiences and preferences regarding treatment, which could help shape better healthcare for others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Prolactinoma patients
- • Prolactinoma treating physicians including endocrinologists and neurosurgeons
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
Cihan Atila
Principal Investigator
University Hospital, Basel, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported